1. Home
  2. > Pharmaceutical Market Trends
Polyvinylpyrrolidone Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

Polyvinylpyrrolidone Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

  • August 2022
  • 178 pages
  • ID: 6316182
  • Format: PDF
  • Mordor Intelligence LLP

Summary

Table of Contents

Search Inside

The market for polyvinylpyrrolidone is estimated to be valued at 75,857.83 tons in 2022 and is expected to register a CAGR of about 8% during the forecast period (2022-2027).

The market was negatively impacted by COVID-19 in 2020. The COVID-19 pandemic affected all the applications of polyvinylpyrrolidone except the pharmaceutical industry. The pandemic has led to disrupted supply chains globally. Lockdowns across different countries have affected production as key manufacturing units and factories were shut. However, the industries has started recovering since then.

Key Highlights
A major factor driving the market studied is a rising demand in the pharmaceutical industry and growing application as adhesives in the construction industry.
The presence of substitute products in the market is supposed to hinder the market growth.
Increasing application scope in the personal care and cosmetic industry will likely act as an opportunity for the market studied.
Asia-Pacific dominated the market and is expected to continue its dominance during the forecast period owing to the growing pharmaceutical industry in the region.

Key Market Trends

Rising Demand in the Pharmaceutical Industry

Polyvinylpyrrolidone or PVP can be used in medical and health fields as a binder, excipients, coating, bounded solution of an agent, cosolvent, sterilization disinfectant, solubilizer, sustained release agent, capsule shell, a dispersion stabilizer, and others due to its excellent solubility, solubilization property, bonding capacity, complexing power, and other functions.
The pharmaceutical industry and medicine are the earliest and probably the most well-known areas to have benefited from PVP due to its extraordinary biocompatibility and ability to create stable association compounds and complexes with various active substances.
According to AstraZeneca and IQVIA, the pharmaceutical sales revenues globally reached USD 1,101 billion in 2020 and increased by 7.72% in 2021 to reach USD 1,186 billion. The United States dominated pharmaceutical sales in 2020 with a share of over 45% or USD 555 billion, while the Europe region stood second with a share of around 20% or USD 228 billion. China, Japan, Canada, India, and Brazil are some of the other major pharmaceutical markets globally.
•As per the United Nations Department of Public Information, compared to 2017, the number of persons aged 60 or above is expected to more than double by 2050 and more than triple by 2100, rising from 962 million globally in 2017 to 2.1 billion in 2050 and 3.1 billion in 2100.
Owing to all the above-mentioned factors rising demand from the pharmaceutical industry is expected to drive the polyvinylpyrrolidone market over the forecast period.

Asia Pacific Region to Dominate the Market

The Asia Pacific region is expected to dominate the market for polyvinylpyrrolidone during the forecast period. In countries, like China, India, and Japan, owing to the growing pharmaceutical industry, the demand for polyvinylpyrrolidone has been increasing in the region.
In China, polyvinylpyrrolidones (PVP) are widely adopted in the pharma industry as a safe binder and blood plasma expander. China is the world’s largest producer of pharmaceutical ingredients. China’s pharmaceutical market value was ~USD 104.9 billion in 2021 and continuously increased during the forecast period. This increase will make China’s pharmaceutical market the second largest in the world, with surging revenue propelling industry value significantly closer to that of the United States.
As of 2021, China holds 12% of the global pharmaceutical market, following the United States, responsible for 40% of the total revenue worldwide. According to Xinhua, the Chinese pharmaceuticals market generated CNY 708.75 billion in 2021, while Chinese domestic pharmaceutical companies amassed USD 502 billion in revenue
According to the Government of India, Indian pharma exports witnessed a growth of 103% from FY 2013 - FY 2014, from INR 904.15 billion in FY 2013 – FY 2014 to INR 1,834.22 billion in FY 2021 – FY 2022, and it is expected to reach INR 10,300.35 billion by FY 2030. The exports achieved in FY 2021 –FY 2022 is the Pharma Sector’s best export performance ever. It is remarkable, with exports growing by almost USD 10 billion in 8 years. India has provided pharmaceutical products to more than 200 countries and may continue to do so in the future.
The pharmaceutical market in Japan has shown small growth rates in the past years. A complex regulatory and pricing process and regular price cuts have made it complicated for pharmaceutical companies to introduce new innovative products. Another reason for the stagnant market is the promotion of generic drugs adopted by the government since 2007 to reduce healthcare expenditures in Japan. Also, the easy availability of pharmaceutical products online and consultation coupled with increased health concerns among the people are likely to augment the polyvinylpyrrolidone market.
The aforementioned factors are expected to increase the demand for polyvinylpyrrolidone in the region during the forecast period.

Competitive Landscape

The polyvinylpyrrolidone market is consolidated in nature, the top three players account for around 60% of the share in the market. Major companies in the market include BASF SE, Ashland, Boai NKY Pharmaceuticals Ltd, JH Nanhang Life Sciences Co., Ltd., and Huangshan Bonsun Pharmaceuticals Co. Ltd, among others.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on